Search
for
Sort by
Research 31–60 of 1000+
- SAT-224 Polycystic Ovary Syndrome with Adrenal Hyperandrogenemia and Refractory Hirsutism
- Medical Treatment of Hirsutism in Women
- [Hirsutism and hypertrichosis in adults: investigations and treatment].
- Miscellaneous Skin Diseases
- Pharmacokinetics and Bioconversion of Dehydroepiandrosterone after Application of Dexamethasone in Women with Polycystic Ovary Syndrome
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- 11β-Hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes
- Profile of the progesterone derivative chlormadinone acetate — Pharmocodynamic properties and therapeutic applications
- Nonclassic adrenal hyperplasia
- Skin steroidogenesis in health and disease
- Coat condition, housing condition and measurement of faecal cortisol metabolites - a non-invasive study about alopecia in captive rhesus macaques (Macaca mulatta)
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Skin and glucocorticoids: effects of local skin glucocorticoid impairment on skin homeostasis
- 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Attenuates the Adverse Effects of Glucocorticoids on Dermal Papilla Cells
- Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor
- The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia
- Cedrol mitigates hepatic lipid accumulation and adipocyte hypertrophy induced by corticosteroids through the inhibition of glucocorticoid receptor activity
- Primary Generalized Glucocorticoid Resistance or Chrousos Syndrome: Allostasis Through a Mutated Glucocorticoid Receptor
- The eye and the skin in endocrine metabolic diseases
- 272 Structural changes in human skin after topical application of glucocorticoids assessed by in vivo imaging technologies
- Potential role and therapeutic interests of myo-inositol in metabolic diseases
- Analysis of metabolic characteristics of epristeride in zebrafish based on LC-Q-TOF MS and its potential applications in doping control
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Is There Really Relationship between Androgenetic Alopecia and Metabolic Syndrome?
- Metabolic syndrome in alopecia areata: an observational study at a tertiary care center
- Evaluation of metabolic and hormonal parameters in women with PCOS living in Black Sea Region
- Comparison of Components of Metabolic Syndrome in Androgenic Alopecia versus Healthy Population
- Clinical aspects of the metabolic syndrome
- Mechanisms of Disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome